Table 6 Breast cancer diagnoses by receptor-based subtypes, proportion ILC, and age and race/ethnicity, SEER 17 registries, 2010–2021

From: Evolving incidence patterns for locally advanced operable breast cancer by receptor status: SEER 2010–2021

 

N2-3M0(Any T)

 

All subtypes

HR+/HER2−

HR+/HER2+ 

TNBC

HR−/HER2+ 

Characteristic

Total (N)

Total (N)

Total (%)a

ILC (N)

ILC (%)b

Total (N)

Total (%)a

ILC (N)

ILC (%)b

Total (N)

Total (%)a

ILC (N)

ILC (%)b

Total (N)

Total (%)a

ILC (N)

ILC (%)b

Age (Years)

                 

 <50

11,629

7324

63.0

967

13.2

1831

15.7

54

2.9

1692

14.5

24

1.4

782

6.7

11

1.4

 ≥50

31,731

21,261

67.0

4566

21.5

4392

13.8

294

6.7

4093

12.9

155

3.8

1985

6.3

46

2.3

Race/Ethnicity

                 

 NH White

26,162

17,943

68.6

3964

22.1

3626

13.9

235

6.5

3105

11.9

120

3.9

1488

5.7

34

2.3

 NH Black

5855

3292

56.2

540

16.4

827

14.1

29

3.5

1281

21.9

24

1.9

455

7.8

6

1.3

 NH American Indian, Alaska Native

218

140

64.2

16

11.4

33

15.1

2

6.1

30

13.8

1

3.3

15

6.9

0

0.0

 NH Asian, PI

4035

2680

66.4

316

11.8

616

15.3

30

4.9

425

10.5

12

2.8

314

7.8

10

3.2

 Hispanic

6881

4392

63.8

684

15.6

1091

15.9

48

4.4

916

13.3

22

2.4

482

7.0

7

1.5

 

T3-4N0-1M0

 

All subtypes

HR+/HER2−

HR+/HER2+

TNBC

HR−/HER2+

Characteristic

Total (N)

Total (N)

Total (%)a

ILC (N)

ILC (%)b

Total (N)

Total (%)a

ILC (N)

ILC (%)b

Total (N)

Total (%)a

ILC (N)

ILC (%)b

Total (N)

Total (%)a

ILC (N)

ILC (%)b

Age (Years)

                 

 <50

10,274

5350

52.1

1074

20.1

1948

19.0

83

4.3

2002

19.5

15

0.7

974

9.5

13

1.3

 ≥50

28,466

17,956

63.1

5297

29.5

3950

13.9

380

9.6

4291

15.1

116

2.7

2269

8.0

53

2.3

Race/Ethnicity

                 

 NH White

23,166

15,091

65.1

4746

31.4

3543

15.3

342

9.7

3223

13.9

82

2.5

1309

5.7

41

3.1

 NH Black

5430

2724

50.2

471

17.3

737

13.6

42

5.7

1482

27.3

15

1.0

487

9.0

11

2.3

 NH American Indian, Alaska Native

177

96

54.2

22

22.9

34

19.2

1

2.9

31

17.5

1

3.2

16

9.0

1

6.3

 NH Asian, PI

3709

2120

57.2

395

18.6

645

17.4

28

4.3

500

13.5

12

2.4

444

12.0

3

0.7

 Hispanic

5630

3141

55.8

705

22.4

910

16.2

48

5.3

1028

18.3

21

2.0

551

9.8

10

1.8

  1. HER2 human epidermal growth factor receptor-2, HR hormone receptor, ILC invasive lobular carcinoma, NH non-Hispanic, PI Pacific Islander, TNBC triple negative breast cancer.
  2. aProportion of receptor-based subtype among diagnoses in each characteristic subgroup.
  3. bProportion ILC among diagnoses of each receptor-based subtype in each characteristic subgroup.